Sicriptin 2.5mg 10 Tablets

Babies: Not applicable. Lactating mothers: It is unsafe to use this medicine during breastfeeding. Studies have shown that the drug causes harm to the baby. Pregnancy: It is safe to use this medicine during pregnancy.
Human studies have shown that the drug does not cause harmful effects on the developing baby. Seek the doctor's advice before using this medicine. Alcohol: It is unsafe to consume alcohol while taking this medicine. Driving: This medicine causes dizziness, weakness and affects your ability to drive.
Do not drive if you experience these symptoms. Kidney: It is safe to use this medicine in patients with kidney disease.
Dose adjustment is not required. Seek a doctor's advice before taking this medicine.
It is not recommended in patients with kidney disease. Liver: Limited studies are available on the use of this medicine in patients with liver diseases. Seek a doctor's advice before using this medicine..

Nausea Vomiting Dizziness Fatigue Headache.

Sicriptin is a dopamine agonist used to treat high prolactin levels in the body, female infertility, and acromegaly. It works by lowering the amount of growth hormone and inhibiting the release of prolactin in the body..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Take this medicine with or after food as prescribed by your doctor to avoid nausea and indigestion. • To get better results to take this medicine at a fixed time. • Finish the course of this medicine. • Inform your doctor if you have a condition called fibrosis before taking this medicine. • If you experience nausea, dizziness, vomiting, fatigue, and headache for a longer duration while taking this medicine, inform your doctor..

Major • Sicriptin + Rizatriptan: Concurrent use of these medicines lead to excessive narrowing of blood vessels in the body • Sicriptin + Sumatriptan: Concurrent use of these medicines lead to excessive narrowing of blood vessels in the body • Sicriptin + Zolmitriptan: Concurrent use of these medicines lead to excessive narrowing of blood vessels in the body • Sicriptin + Almotriptan: Concurrent use of these medicines lead to excessive narrowing of blood vessels in the body • Sicriptin + Eletriptan: Concurrent use of these medicines lead to excessive narrowing of blood vessels in the body Moderate • Sicriptin + Alprazolam: Concurrent use of these medicines lead to an increase in the risk of dizziness and drowsiness • Sicriptin + Amitriptyline: Concurrent use of these medicines lead to an increase in the risk of dizziness and drowsiness • Sicriptin + Baclofen: Concurrent use of these medicines lead to an increase in the risk of dizziness and drowsiness • Sicriptin + Citalopram: Concurrent use of these medicines lead to an increase in the risk of dizziness and drowsiness • Sicriptin + Dantrolene: Concurrent use of these medicines lead to an increase in the risk of dizziness and drowsiness.